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Дослідити чутливість планктонних і плівкових форм C. albicans та C. glabrata до антисептиків на основі катіонних 
поверхнево-активних речовин (ПАР).  Матеріали та методи дослідження. Об’єктом дослідження стали 20 клінічних 
штамів C. albicans та 15 C. glabrata, виділених від хворих хірургічних відділень. Чутливість планктонних форм дос-
ліджуваних штамів мікроорганізмів до антисептичних засобів вивчали за допомогою кількісного макрометоду по-
двійних серійних розведень у рідкому поживному середовищі Сабуро. Біоплівкоутворюючі властивості досліджу-
ваних клінічних штамів визначали за допомогою спектрофотометричного методу за G.D. Christensen (MtP-test). 
Вплив антисептиків на плівкові форми Candida spp. визначали шляхом відтворення біоплівок за вищеописаною 
методикою з додаванням суббактеріостатичних концентрацій антисептиків. В дослідженні використовували анти-
септики на основі катіонних ПАР хлоргексидину біглюконат 0,05 (Хлоргексидин-КР, виробництва ПАТ «Хімфармза-
вод «Червона зірка», м. Харків, Україна (ХГ))  та декаметоксин 0,2 (Декасан, виробництва ТОВ «Юрія-Фарм», м. 
Київ, Україна (ДКМ)). Результати. За результатами досліджень встановлено нижчу чутливість штамів C. glabrata до 
ХГ, у порівнянні з чутливістю штамів C. albicans. Поряд з цим, активність ДКМ щодо досліджуваних представників 
Candida spp. достовірно не відрізнялась. Клінічні штами C. glabrata виявилися більш чутливими до ДКМ порівняно 
з їх чутливістю до ХГ. Штами C. albicans проявили середні плівкоутворюючі властивості, в той час як C. glabrata – 
високі. Досліджувані антисептики на основі катіонних ПАР володіли в однаковій мірі потужною активністю щодо 
плівкоутворення клінічних штамів Candida spp. Висновки. Антисептики на основі катіонних ПАР (ХГ та ДКМ) воло-
діють протигрибковою активністю щодо планктонних і плівкових форм клінічних штамів C. albicans та C. glabrata.  
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The aim of the study was to investigate the sensitivity of planktonic and film forms of C. albicans and C. glabrata to cati-
onic surfactant antiseptics. Materials and methods. The study was based on investigating 20 clinical strains of C. albicans 
and 15 C. glabrata isolated from surgical inpatientsю.  The sensitivity of planktonic forms of investigated strains to anti-
septic agents was quantitatively evaluated by two-fold serial dilutions (macrodilution) in Sabouraud liquid nutrient me-
dium. Biofilm-forming properties of clinical strains C. albicans and C. glabrata were assessed by using the Christensen’s 
spectrophotometric method (MtP-test “microtiter plate test”). The influence of the antiseptics on C. albicans and C. 
glabrata film forms was assessed by the reproduction of the biofilms according to the above-described procedure with 
adding antiseptics in sub-bacteriostatic concentrations and the subsequent spectrophotometric ODU assessment. In the 
study we used antiseptics based on cationic surfactants, chlorhexidine digluconate 0.05 (Chlorhexidine-KR, manufactured 
by PJSC “Khimfarmzavod “Chervona zirka"”, Kharkiv, Ukraine (CHH)) and decamethoxin 0.2 (Decasan, produced by Yu-
ria-Farm LLC ", Kyiv, Ukraine (DCM)). Results. According to the research results, lower sensitivity of C. glabrata strains to 
CHH was found, compared to the sensitivity of C. albicans strains. In addition, the activity of DCM in the investigated 
representatives of Candida spp. did not differ significantly. Clinical strains of C. glabrata were more susceptible to DCM 
compared to their susceptibility to CHH. C. albicans strains showed medium film-forming properties, while C. glabrata - 
high. The investigated cationic surfactant antiseptics possessed the same degree of activity on the film-forming proper-
ties of clinical strains of Candida spp. Conclusions.  Cationic surfactant antiseptics (CHH and DCM) possess antifungal 
activity against planktonic and film forms of C. albicans and C. glabrata. 
Key words: Candida, cationic surfactant antiseptics, sensitivity, biofilm. 
Introduction 
Yeast-like fungi that belong to the genus Candida are 
known to be an inseparable component of human micro-
biota. However, immune deficiency conditions or / and 
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impaired homeostasis can contribute to the development 
of candidiases [1]. 
According to the relevant literature, until the beginning 
of the 21st century yeast fungi caused about 3% of post-
operative infectious complications [2]. Lately, however, 
Candida spp. has been reported to as a rapidly growing 
cause of infectious post-operative complications. Fungal 
infections have been found out to result in high mortality 
rate, which sometimes reaches the rates of deaths due to 
tuberculosis and malaria [3]. Fungi of the genus Candida 
rank the sixth place among the main nosocomial patho-
gens and the fourth place among the dominant causative 
agents of nosocomial bacteria. This is due to the decline 
in community immunity among the population, alterations 
in the biological properties of pathogens and the rapid 
development of microbial resistance to antimicrobial 
agents [2, 4]. In order to improve the situation it is of 
great importance to reconsider and update existing 
treatment standards.  
In the past, C. albicans was known as the most 
prevalent species of Candida spp. throughout the world 
and described as a causative agent of about two thirds of 
all cases of invasive candidiasis [5]. However, today 
there are some changes within the spectrum of etiologi-
cal factors of candidiasis infection that indicate a growing 
shift towards the so-called non-albicans species (C. 
glabrata, C. krusei, C. tropicalis) [5-7]. 
While C. albicans, C. krusei, C. tropicalis are geneti-
cally related, C. glabrata does not have a close phyloge-
netic relationship with other members of the genus. This 
determines the existence of significant differences in their 
morphology, pathogenicity factors, sensitivity to medica-
tions and thus the pathogenesis of mycoses caused by 
this causative agent [8]. This requires a comprehensive 
in-depth study of the biological properties of Candida 
spp. within the boundaries of the genus and the search 
for medicines that would have the same equal antifungal 
effect on different representatives of the genus. 
The aim  
 
of the study was to investigate the sensitivity of plank-
tonic and film forms of C. albicans and C. glabrata to 
cationic surfactant antiseptics. 
Materials and methods 
The study was based on investigating 20 clinical 
strains of C. albicans and 15 C. glabrata isolated from 
surgical inpatients staying at M. Sklifosovskiy Poltava 
Regional Clinical Hospital and M. Pyrogov Vinnytsia Re-
gional Clinical Hospital. The research has been carried 
out according to Helsinki Declaration on the ethical prin-
ciples for medical research involving human subjects and 
approved by the Bioethics Committee of M. Pyrogov Vin-
nytsia National Medical University and the Commission 
on Ethical Issues and Bioethics of Ukrainian Medical 
Stomatological Academy. 
To investigate the microflora, the material was taken 
from the surface of the infected surgical wound, followed 
by cultivation on Sabouraud culture medium for 48 hours. 
The final identification was carried out in accordance with 
the standard methodology for morphological, tinctorial 
and biochemical properties and by applying automatic 
bacteriological analyzer Vitec - 2compact bioMérieux 
(France). 
The sensitivity of planktonic forms of investigated 
strains to antiseptic agents was quantitatively evaluated 
by two-fold serial dilutions (macrodilution) in Sabouraud 
liquid nutrient medium  in accordance with the Order of 
the Ministry of Public Health of Ukraine No. 167, April 5, 
2007 "On Approval of Methodological Instructions on 
"Assessment of Sensitivity of Microorganisms to Antibac-
terial Drugs "[9]. For this purpose, a microbial suspension 
(inoculum) equivalent to 1.0 was prepared according to 
the McFarland standards, and diluted 100-fold in a saline, 
after that the microbial concentration obtained was 
3x1010 CFU / cm3. Then, inoculums prepared ex tem-
pore and taken in a dose of 1.0 ml were applied into each 
test tube with a two-fold dilution of antiseptic solution and 
into one test tube containing 1.0 ml of nutrient broth 
("negative" control). All test tubes with the exception of 
"negative" control were incubated in the standard atmos-
phere at 35 ° C for a day. The "negative" control test tube 
was kept at a temperature 4 ° C until the results were re-
corded. 
Biofilm-forming properties of clinical strains C. albi-
cans and C. glabrata were assessed by using the Chris-
tensen’s spectrophotometric method (MtP-test “microtiter 
plate test”). Biofilms were modelled in Sabouraud liquid 
nutrient medium in wells of a sterile, flat-bottom 96-well 
polystyrol tablet (Corning, USA) and stained with 1% so-
lution of crystalline violet. The properties of microorgan-
isms to form a biofilm were measured by absorbance of 
the dye in units of optical density (ODU) using a spectro-
photometer with a wavelength of 570 nm. The ability of 
microorganisms to form biofilms was evaluated as low 
(ODU <0.120), average (ODU = 0.121-0.239) and high 
(ODU > 0.240) [10]. 
The influence of the antiseptics on C. albicans and C. 
glabrata film forms was assessed by the reproduction of 
the biofilms according to the above-described procedure 
with adding antiseptics in sub-bacteriostatic concentra-
tions and the subsequent spectrophotometric ODU as-
sessment.  
In the study we used antiseptics based on cationic 
surfactants, chlorhexidine digluconate 0.05 (Chlorhexi-
dine-KR, manufactured by PJSC “Khimfarmzavod “Cher-
vona zirka"”, Kharkiv, Ukraine (CHH)) and decamethoxin 
0.2 (Decasan, produced by Yuria-Farm LLC ", Kyiv, 
Ukraine (DCM)). 
The statistical analysis of the obtained findings was 
performed by using the standard SPSS Statistics 23 and 
Microsoft Excel 2010 software packages. We calculated 
the arithmetic mean (M), the mean error of the arithmetic 
mean (± m), and the criterion of the reliability of the dif-
ferences (p). The differences between the indicators 
studied were evaluated according to Student's t-test. 
Results and discussion 
The obtained findings demonstrated that CHH and 
DCM were found to produce varying antifungal effect on 
investigated clinical strains of yeast fungi (Table 1). The 
minimum inhibitory concentration (MIC) and the minimum 
fungicidal concentration (MFcC) of CHH for C. glabrata 
significantly exceeded the MIC and MFcC showed by 
DCM for C. albicans in 1.6 times (p <0.05). This indicated 
a lower sensitivity of C. glabrata strains to CHH when 
compared with the C. albicans strain sensitivity. In addi-
tion, the activity of DCM against the investigated repre-
sentatives of Candida spp. did not differ significantly (p 
<0.05). However, it should be noted that MFcC demon-
strated by DCM against  clinical strains of C. glabrata 
was 1.7 times lower than MFcC of CHH against the rele-
vant strain (p <0.05). This pointed out a significantly 
higher sensitivity of C. glabrata to DCM than to CHH. 
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Table 1 
Susceptibility of Candida spp clinical strains to antiseptics, 10-3 mg/ml, M±m 
Chlorhexidine digluconate Decamethoxin 
Microorganism N 
МІC MFcC МІC MFcC 
C. albicans 20 3,02±1,48 4,39±2,18 3,51±1,75 5,55±3,38 
C. glabrata 15 4,93±2,20* 7,29±3,87** 3,13±1,77 4,38±1,89§ 
Note:         * - the reliability of the difference between the chlorhexidine digluconate MIC values relative to C. glabrata and  the chlor-
hexidine digluconate MIC values relative to C. albicans, p <0,05;  
** - the reliability of the difference between the chlorhexidine MFcC digluconate values relative to C. glabrata to the MFTSC 
values of chlorhexidine digluconate relative to C. albicans, p <0,05; §- the reliability of the difference between the decameth-
oxin MFcC values relative to C. glabrata and the  chlorhexidine digluconate MFcC values relative to C. glabrata, p <0.05. 
The study showed the representatives of the genus 
Candida differed in their ability to biofilm formation (Fig. 
1). The ability to absorb the dye by C. glabrata (0,251 ± 
0,04 ODU) exceeded the C. albicans values (0,203 ± 
0,05 ODU) in 1,2 times (p = 0,004), i.e. the clinical strains 
of C. albicans demonstrated average film-forming proper-
ties, while those of C. glabrata strains were higher. 
It should be noted that the cationic surfactants anti-
septics studied had a strong activity against the film for-
mation by Candida spp. clinical strains. CHH contributed 
to a decrease in the optical density of the biofilms of the 
investigated fungi species in 1,1 times (p = 0,001), com-
pared with their indices without the presence of the anti-
septics. Similarly, there was a decrease in the film-
forming properties by C. albicans and C. glabrata in the 
presence of DCM in a 1.1 time and 1.3 times respec-
tively, compared with baseline (p = 0.001). 
* 
** ** 
*** *** 
 
Fig. 1. Characteristics of biofilm-forming properties of Candida spp. clinical strains in the presence of antiseptics 
(* - the reliability of the differences between the ODU value of C. glabrata biofilms  
and the  ODU value of C. albicans biofilms, p <0.001;  
** - the reliability of the differences between the ODU value of C. albicans biofilms in the incidence of CHH and DCM  
and the ODU values demonstrated by biofilms without antiseptics, p <0.001;  
*** - the reliability of the difference of the ODU value of the C. glabrata biofilms in the presence of CHH  
and DCM to the index of ODU values demonstrated by biofilms without antiseptics , p <0.001). 
The biofilm formation by C. albicans is known to start 
by the microorganism adhesion to the artificial surface 
with the subsequent production of the extracellular ma-
trix. Cells embedded into this matrix multiply, forming a 
biofilm. In turn, the ability of C. glabrata to form a similar 
extracellular matrix has not been experimentally proven. 
Accordingly, the powerful film-forming properties of the 
latter are genetically determined and associated with the 
presence of a number of surface adhesins involved in the 
process of biofilm formation. Recently, the genome of 
representatives of the Candida species is being actively 
studied, establishing a connection between their strains’ 
properties of biofilm formation and the presence of 
surperficial  Epa6, Epa7 and other proteins [11]. 
Cationic surfactant antiseptics used in the study have 
been found out to reliably suppress the biofilm-forming 
properties of both C. albicans clinical strains and C. 
glabrata strains, which are different from C. albicans by 
their biological properties. The mechanism of action of 
the drugs of this group consists in the ability to change 
the surface tension of the cell of the microorganism. It 
impacts the surface structure of the cell and stimulates 
the disruption of its osmotic balance, resulting in "osmotic 
shock" and the death of the microorganism [12]. 
The obtained results point out the high efficacy of 
cationic surfactant antiseptics on planktonic and film 
forms of Candida spp. clinical strains. The equally potent 
anti-fungal action of CHH and DCM against both C. albi-
cans and C. glabrata strains makes the medicines stud-
ied appropriate in the treatment of candidiasis in view of 
the significant differences in their antimycotic effects to 
microbes within the genus. 
Conclusions 
Cationic surfactants antiseptics (CHH and DCM) pos-
sess antifungal activity against clinical strains of Candida 
spp. Clinical strains of C. albicans demonstrate higher 
susceptibility to CHH, compared with the clinical strains 
of C. glabrata. In turn, DCM has a significantly higher 
anti-fungal effect against C. glabrata, compared with 
CHH. C. albicans clinical strains show average biofilm 
properties, while C. glabrata strains have high biofilm-
forming properties. CHH and DCM significantly inhibit the 
ability to form biofilms by clinical strains of Candida spp. 
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